Renal insufficiency
Drug research and approvals for renal insufficiency: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 740 studies of renal insufficiency are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and the EU has 4 authorised medicines for it.
- Recruiting worldwide: 740
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 4
Recruiting Now
Newest start dates first, of 740 recruiting on ClinicalTrials.gov ↗- Breakthrough - T1DM and Chronic Kidney DiseaseNCT07592000 · Phase 1 / Phase 2 · University of Chicago · starts Apr 29, 2027
- Effects of Replacing High Protein Foods in People With Chronic Kidney DiseaseNCT07105670 · Not applicable · Indiana University · starts Feb 1, 2027
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine,…NCT07083557 · Not reported · Bettina Mittendorfer · starts Jan 1, 2027
- Clinical Decision Support for SGLT2i After AKI in Type 2 DiabetesNCT07868666 · Not applicable · University of Minnesota · starts Nov 2, 2026
- Pharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Varying Degrees of Renal…NCT07938515 · Phase 1 · Chendu DIAO Pharmaceutical Group CO., LTD. · starts Nov 2, 2026
- Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal DiseaseNCT07696962 · Phase 1 · Xeno Holdings (US), LLC dba ChoironeX · starts Nov 1, 2026
- Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney DiseaseNCT07911124 · Phase 2 · University of Arkansas · starts Nov 1, 2026
- Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRDNCT07224763 · Phase 1 / Phase 2 · United Therapeutics · starts Nov 1, 2026
- Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot TrialNCT07910773 · Not applicable · University of California, San Francisco · starts Oct 30, 2026
- A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney…NCT07916181 · Phase 1 · Basilea Pharmaceutica · starts Oct 27, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Jan 23, 2019 | Pharmacokinetic of tobramycin administered at the beginning of an intermittent hemodialysis session (esrd study)TOBRAMYCIN | CENTRE INTEGRE UNIVERSITAIRE DE SANTE ET DE SERVICES SOCIAUX DE L'EST DE MONTREA | Ongoing |
| Dec 22, 2015 | Study of the bioaccumulation of tinzaparin in renally impaired patients when given at prophylactic dosesINNOHEP | HOPITAL MAISONNEUVE ROSEMONT | Pending |
| May 22, 2013 | A phase I, multi-center, non-randomized, open label, parallel-group study evaluating the pharmacokinetics and safety of regorafenib (bay 73-4506) in cancer…REGORAFENIB (BAY 73-4506) | Bayer | Closed |
| May 8, 2013 | "a phase IIIb open label study to optimize the single bolus dose of dalteparin sodium for the prevention of clotting within the extracorporeal system during…FRAGMIN (DALTEPARIN SODIUM) | Pfizer | Ongoing |
| Apr 12, 2013 | A phase II multi-center, parallel-group, randomized, double blind, proof-of-concept, adaptive study investigating the safety and efficacy of thr-184…THR-184 | THRASOS INNOVATION INC | Closed |
Medicines Authorised in the EU
Newest first| Apr 24, 2023 | Vafseovadadustat | Medice Arzneimittel Pütter GmbH & Co. KG | EMA ↗ |
| Feb 16, 2022 | Kerendiafinerenone | Bayer AG | EMA ↗ |
| May 27, 2015 | Jinarctolvaptan | Otsuka Pharmaceutical Netherlands B.V. | EMA ↗ |
| Feb 2, 2005 | Fendrixhepatitis B (rDNA) vaccine (adjuvanted, adsorbed) | GlaxoSmithKline Biologicals S.A. | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA